Brief: Redwood Pharma enters into agreement with CRO for clinical phase II trial
Sept 1 (Reuters) - REDWOOD PHARMA AB REDWPH.ST :
* ENTERS INTO AGREEMENT WITH CRO FOR CLINICAL PHASE II TRIAL
Source text for Eikon: ID:nWkr9Rl3s3
Further company coverage: REDWPH.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Redwood Pharma AB
See all newsBrief: Redwood Pharma Says Files For Bankruptcy
Brief: Redwood Pharma Provides New Update Regarding Divestment Of Company Assets
Brief: Redwood Pharma Updates On Process For Divesting Assets
Brief: Redwood Pharma To Propose Liquidation At EGM
Brief: Redwood Pharma: Minimum Level In Rights Issue Not Reached